Dezhan Healthcare Company Limited (SZSE: 000813)
Health Care · Pharmaceuticals · CN
CN¥3.27
-6.84% today · -18.7% 1Y
Dezhan Healthcare Company Limited (SZSE: 000813) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.02B and employs 1,195 people.
Over the last twelve months the share price has lost 18.7%, trading between 2.75 and 4.93.
Tweenvest scores Dezhan Healthcare Company Limited across four factors: quality 64/100, value 52/100, growth 0/100. Its strongest factor is quality.
000813 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.02B
- Revenue (TTM)
- $57.44M
- P/E
- —
- EPS
- -0.17
- Dividend yield
- —
- Beta (5Y)
- 0.39
- 52-week high
- CN¥4.93
- 52-week low
- CN¥2.75
- Avg volume (3M)
- —
- Shares outstanding
- 2.10B
- Employees
- 1,195
- Next earnings
- —
About Dezhan Healthcare Company Limited
Dezhan Healthcare Company Limited operates primarily within the Chinese market, specializing in the research, development, manufacturing, and distribution of pharmaceutical products, with a particular focus on cardiovascular and cerebrovascular medications. The company's product range also extends to include oncology drugs, a variety of health and wellness products, functional beverages, and ecological water. Established in 1998, the firm maintains its headquarters in Urumqi, China.
- ISIN
- CNE000000VV8
- Founded
- 1980
- Listed since
- May 19, 1998
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,262.50 | +0.57% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.94 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | 0.00% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.90 | -1.52% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.80 | -1.31% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.